Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00739401 · ClinicalTrials.gov registry record · NA
Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm
A NA study of Abdominal Aortic Aneurysm, sponsored by Endologix.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 8
- Study locations
NCT00739401: Completed NA study of Abdominal Aortic Aneurysm, sponsored by Endologix.
NCT00739401 is a NA study of Abdominal Aortic Aneurysm that has completed, run by Endologix. The registered enrollment target is 44 participants, below the 451-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (90% lower). The trial reports 8 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00739401, a NA study of Abdominal Aortic Aneurysm, has completed, sponsored by Endologix.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 8
- Study locations
Study Summary
The use of a suprarenal extension device during the index AAA procedure to accommodate the patient's anatomy and to prevent or repair leakage.
Primary Outcome
The primary study endpoint is defined as the incidence of type I proximal endoleak at 30 days post-treatment.
Conditions Studied
Interventions
- DEVICE Suprarenal Proximal Cuff Extension
Study Locations (8)
Florida
- Mount Sinai Medical Center - Miami Beach
- Munroe Regional Medical Center - Ocala
- Orlando Regional Hospital - Orlando
- Sacred Heart Hospital - Pensacola Research Consultants - Pensacola
North Carolina
- Duke University Hospital - Durham
- East Carolina University - Brody School of Medicine - Greenville
Illinois
- Methodist Medical Center of Illinois - Peoria
Indiana
- Deaconess Hospital - The Heart Group - Evansville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2006-05-05 |
| Est. Completion | 2009-08 |
| Phase | NA |
What the finished NCT00739401 record still lists
NCT00739401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 451-participant average among 16 other Abdominal Aortic Aneurysm trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Abdominal Aortic Aneurysm appearing as the primary indexed condition, and to 1 intervention - of which Suprarenal Proximal Cuff Extension is the first listed.
NCT00739401 lists 8 locations in 4 states (Florida, North Carolina, Illinois).
Frequently Asked Questions
What is clinical trial NCT00739401 about?
NCT00739401 is a clinical study titled "Suprarenal Proximal Cuff Study for Treatment of Abdominal Aortic Aneurysm". The use of a suprarenal extension device during the index AAA procedure to accommodate the patient's anatomy and to prevent or repair leakage.
What is the current status of trial NCT00739401?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2006-05-05. Estimated completion is 2009-08.
What conditions does trial NCT00739401 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm.
What interventions are being tested in trial NCT00739401?
The interventions under investigation include: Suprarenal Proximal Cuff Extension (DEVICE).
Who is sponsoring clinical trial NCT00739401?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00739401 being conducted?
This trial has 8 study locations across Florida, Illinois, Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00739401's enrollment target sits among peer trials
44 12th of 16 higher than 5 of 16 other Abdominal Aortic Aneurysm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abdominal Aortic Aneurysm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE Trial
RECRUITING · NA
-
Estimation of Biomechanical Aortic Wall Properties in Healthy and Aneurysmal Aortas Using Novel Imaging Techniques
RECRUITING · NA
-
Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)
RECRUITING · NA
-
3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair
ACTIVE NOT RECRUITING · NA
-
Post-Approval Study of the TREO Abdominal Stent-Graft System
ACTIVE NOT RECRUITING · NA
-
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI